Side-by-side comparison of AI visibility scores, market position, and capabilities
Unified patient communication and engagement platform for healthcare providers, combining messaging, scheduling, and care navigation. Santa Barbara CA, raised $45M+.
Well Health is a patient communication and engagement company that provides healthcare organizations with a unified platform for interacting with patients across their entire care journey. Founded in 2015 and headquartered in Santa Barbara, California, Well has raised more than $45 million from investors including Anthem and Premera Blue Cross. The platform consolidates multiple patient communication channels — including SMS, email, in-app messaging, and phone — into a single interface, enabling providers to send appointment reminders, conduct patient surveys, deliver post-visit care instructions, and manage two-way conversations from one tool.\n\nWell Health differentiates itself by providing a conversational AI layer that can handle routine patient inquiries autonomously while escalating more complex issues to staff members. The platform is designed to support the workflows of front desk teams, care coordinators, and patient navigators, giving them a unified inbox and automation tools that reduce the number of separate systems they need to manage. Integration with Epic and other EHR systems allows patient data to flow into communication workflows, enabling personalized and contextually relevant outreach.\n\nThe company serves a diverse range of healthcare organizations including large physician groups, hospital outpatient departments, and specialty practices. Well Health's position as a patient communication infrastructure provider has become increasingly strategic as health systems invest in improving patient access, reducing no-show rates, and maintaining engagement between visits. The company competes with Klara, Luma Health, Relatient, and other patient communication platforms in a market consolidating around full-lifecycle engagement solutions.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.